共 23 条
[1]
ACC/AHA 2005 guidline updale for diagnosis and managemenl of chronic heart failure in the adull-summary article. Hunt SA,Abraham WT,Chin M,et al. Circulation . 2005
[2]
Effects of carvedilol on plasma B-type natriuretic peplide concentration and symptoms in patients with hearl failure and preserved ejection fraction. Takeda Y,Fukutomi T,Suzuki S,et al. The American Journal of Cardiology . 2004
[3]
Aetiology , comorbidity and drug therapy of chronic hearl failure in the real word:the EPICA substudy. Ceia F,Fonseca C,Mola T,et al. European Journal of Heart Failure . 2004
[4]
Predictors of mortality in patients with heart failure and preserved systolic function in the digitalis investigation group trail. Jones RC,Francis GS,Lauer MS. Journal of the American College of Cardiology . 2004
[5]
Epidemiology of diastolic heart failure. Owan TE,Redfield MM. Progress in Cardiovascular Diseases . 2005
[6]
Comparison of outcomes of while versus black patients hospitalized with heart failure and preserved ejection fraction. Agoston J,Cameron CS,Yao D,et al. The American Journal of Cardiology . 2004
[7]
Effects of candesartan in patients with chronic heart failure and peserved left ventricular ejection fraction:the CHARM preserved lrial. Yusuf S.Pfeffer MA,Swedberg K,et al. The Lancet . 2003
[8]
Effect of carvedilol on diastolic function in patients with diaslolic heart failure and preserved systolic function, results of the Swedish Doppler echocardiographic study (SWEDIC ). Bergstrom A,Anderson B,Edner M,et al. Eur J Hearl Fail . 2004
[9]
The epidemiological enigma of heart failure with preserved systolic function. Thomas MD,Fox KF,Coats AJS,et al. European Journal of Heart Failure . 2004
[10]
Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive hearl failure and preserved left ventricular ejection fraction. Kasama S,Toyama T.Kumakura H,et al. Journal of the American College of Cardiology . 2005